Huron Consulting Group Inc. (HURN)
Fair bewertetFundamental
70
Kurs
$169.14
Marktkapitalisierung
$2.50B
Teil 1 · Was das Unternehmen wert ist
Übersicht
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18. September 2026 with claude-haiku-4-5 — shared with all users
Guidehouse, which absorbed Navigant's healthcare practice, sells the same hospital and health-system performance improvement, revenue cycle and research administration advisory that Huron's Healthcare and Education segments live on.
Chartis is a pure-play healthcare advisory firm bidding for the same strategy, clinical and operational transformation projects at US hospitals and academic medical centers that make up Huron's largest segment.
FTI's corporate finance and business transformation practice competes with Huron for performance improvement, restructuring and financial advisory mandates from the same US corporate and healthcare clients.
Accenture competes head-on with Huron's Digital capability, implementing the same Oracle, Workday and Salesforce platforms for health systems and universities, with far greater scale.
Deloitte's healthcare and higher-education consulting practices pursue the same hospital and university transformation budgets, and Huron's 10-K names the consulting arms of the major accounting firms among its competitors.
ICF sells advisory and technology implementation services to public-sector, health and research institutions, overlapping with Huron's Education and Commercial segments.
Bilanz & Liquidität
Umsatz
$1.75B
Letzte 12 Monate (bis 31.3.2026)
Nettogewinn
$104M
Letzte 12 Monate (bis 31.3.2026)
Freier Cashflow
$183M
Gesamtes Eigenkapital
$529M
Gesamtverbindlichkeiten
$998M
Current Ratio
2.22
Zinsdeckungsgrad
-
Schulden/EBITDA
4.21
Gewinn je Aktie
Umsatz & Nettogewinn
Freier Cashflow
Ertragsaufschlüsselung
Historische Aufstellung
Margen im Zeitverlauf
Verschuldung im Zeitverlauf
Wie schwer die Schulden wiegen
Wachstumsraster
Wachstum — Umsatz
Innerer-Wert-Schätzung
Innerer Wert
$183.81
Aktueller Kurs
$169.14
Sicherheitsmarge
+8.0%
Innerer-Wert-Spanne
$119.48 - $248.15
Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.
Bewertungsmethoden
Bewertungskennzahlen
P/E-Verhältnis
26.81
ROE
19.9%
P/B-Verhältnis
6.40
P/FCF
20.54
Bruttomarge
-
ROIC
10.6%
Rentabilitäts-Radar
Wertschöpfung (Wettbewerbsvorteil)
ROIC
10.6%
WACC
5.9%
ROIC − WACC
+4.7 pp
Der ROIC übersteigt die Kapitalkosten: Das Unternehmen schafft Wert für die Aktionäre.
Fundamentalanalyse-Kriterien
Bestanden (18)
- EPS shows upward trend
- EPS CAGR 15.16%
- Price CAGR 12.19%
- ROIC 10.6%
- P/FCF 20.54
- Debt/Equity ratio
- Operating Margin 10.4%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 25.5%
- Revenue Growth 5Y 14.3%
- Analyst Consensus 91% Buy
- Earnings Surprise avg 9.0%
- Earnings Quality (OCF/NI) 1.33
- Share Dilution -3.3%
Nicht bestanden (6)
- P/B Ratio 6.40
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 5.9% vs 7.9%
- Piotroski F-Score 4/9
Nicht verfügbar (4)
- Gross Margin NaN%
- Dividend Payout NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Gemischte Signale: Einige Bereiche bedürfen Aufmerksamkeit
Gewinnqualität
Hohe Qualität: Gewinne durch Cashflow gedeckt
Aktienverwässerung
Aktienrückkäufe. Aktionärsfreundlich
Institutionelle Beteiligungen
Unternehmensführung
Führungsteam
| Name | Position | Alter |
|---|---|---|
| Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. | President, CEO & Director | 64 |
| Mr. John D. Kelly CPA, M.S. | Executive VP, CFO & Treasurer | 48 |
| Mr. J. Ronald Dail | Executive VP & COO | 54 |
| Ms. Hope E. Katz J.D. | Executive VP, General Counsel & Corporate Secretary | - |
| Mr. Kyle D. Featherstone | Chief Accounting Officer & Corporate VP | 44 |
| Mr. Sean Freeburger | Chief Information Officer | - |
| Allie Bovis | Director of Communications | - |
| Elizabeth Entinghe | Corporate Vice President of Corporate Development | - |
| Sarah McHugh | Corporate VP & Chief Marketing Officer | - |
| Ms. Kristen Bruner | Chief Human Resources Officer & Corporate VP | - |
Prüfungsrisiko
1
Vorstandsrisiko
3
Vergütungsrisiko
3
Aktionärsrechterisiko
6
Teil 2 · Der Preis und der Einstiegszeitpunkt
Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.
Dokumente
- Dokument ansehen
Jahresbericht (10-K)
Ein jährlicher Überblick über das Geschäft, die Finanzergebnisse und die Risiken des Unternehmens.
Eingereicht am 2026-02-24
- Dokument ansehen
Quartalsbericht (10-Q)
Ein Update zur finanziellen Entwicklung der letzten drei Monate.
Eingereicht am 2026-07-28
- Dokument ansehen
Ad-hoc-Meldung (8-K)
Eine Mitteilung über ein wichtiges Ereignis, etwa einen Führungswechsel oder eine bedeutende Ankündigung.
Eingereicht am 2026-07-28
via SEC EDGAR
Ertragshistorie
via SEC EDGAR
Latest News
Recent headlines for HURN, sourced from Markets Gazette.
- 5/5/2026NEUTRALHuron Consulting Gr Q1 2026 Earnings Call Transcript
Huron Consulting Group Inc. (HURN) released its Q1 2026 Earnings Call Transcript on May 5, 2026. The transcript provides detailed insights into the company's financial performance, strategic initiatives, and outlook for the upcoming quarters. While specific financial figures and forward-looking statements are discussed, the transcript itself is an informational document rather than a direct announcement of new performance data or significant strategic shifts that would immediately impact the stock price. Investors can use this transcript to gain a deeper understanding of management's perspective and the underlying business drivers.
via Markets Gazette